awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33409982-3F380A83-C932-4BDC-A1F3-7F073B6BC5D3
Q33409982-3F380A83-C932-4BDC-A1F3-7F073B6BC5D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33409982-3F380A83-C932-4BDC-A1F3-7F073B6BC5D3
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas.
P2860
Q33409982-3F380A83-C932-4BDC-A1F3-7F073B6BC5D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33409982-3F380A83-C932-4BDC-A1F3-7F073B6BC5D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc28491b1d0c502b2ffcce85f3abb47421e43f19
P2860
Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma.